Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1950 1
1955 2
1957 1
1958 1
1959 4
1961 1
1962 3
1963 9
1964 4
1965 6
1966 8
1967 7
1968 2
1969 1
1970 2
1971 3
1972 4
1973 2
1974 1
1975 3
1976 1
1977 2
1978 2
1979 7
1980 8
1981 9
1982 13
1983 11
1984 21
1985 26
1986 28
1987 28
1988 26
1989 37
1990 32
1991 39
1992 55
1993 34
1994 39
1995 67
1996 72
1997 79
1998 74
1999 98
2000 113
2001 108
2002 160
2003 165
2004 208
2005 241
2006 265
2007 265
2008 379
2009 422
2010 463
2011 496
2012 513
2013 601
2014 699
2015 784
2016 800
2017 807
2018 1022
2019 1122
2020 1337
2021 1651
2022 1792
2023 1748
2024 609

Text availability

Article attribute

Article type

Publication date

Search Results

15,826 results

Results by year

Filters applied: . Clear all
Page 1
A second-generation M1-polarized CAR macrophage with antitumor efficacy.
Lei A, Yu H, Lu S, Lu H, Ding X, Tan T, Zhang H, Zhu M, Tian L, Wang X, Su S, Xue D, Zhang S, Zhao W, Chen Y, Xie W, Zhang L, Zhu Y, Zhao J, Jiang W, Church G, Chan FK, Gao Z, Zhang J. Lei A, et al. Among authors: lu s. Nat Immunol. 2024 Jan;25(1):102-116. doi: 10.1038/s41590-023-01687-8. Epub 2023 Nov 27. Nat Immunol. 2024. PMID: 38012418
Perioperative Toripalimab Plus Chemotherapy for Patients With Resectable Non-Small Cell Lung Cancer: The Neotorch Randomized Clinical Trial.
Lu S, Zhang W, Wu L, Wang W, Zhang P; Neotorch Investigators; Fang W, Xing W, Chen Q, Yang L, Mei J, Tan L, Sun X, Xu S, Hu X, Yu G, Yu D, Yang N, Chen Y, Shan J, Xing L, Tian H, Zhang X, Zhou M, Fang H, Wu G, Liu Y, Ye M, Cao L, Jiang J, Li X, Zhu L, Li D, Kang M, Zhong A, Chen K, Wu N, Sun Q, Ma H, Cai K, Wang C, Lin G, Zhu K, Zhang Y, Zhang X, Hu H, Zhang W, Chen J, Yang Z, Hang X, Hu J, Huang Y, Zhang Z, Zhang L, Zhang L, Liu L, Lin D, Zhang J, Chen G, Li Y, Zhu L, Wang W, Yu W, Cao D, Keegan P, Yao S. Lu S, et al. JAMA. 2024 Jan 16;331(3):201-211. doi: 10.1001/jama.2023.24735. JAMA. 2024. PMID: 38227033 Clinical Trial.
A GIPR antagonist conjugated to GLP-1 analogues promotes weight loss with improved metabolic parameters in preclinical and phase 1 settings.
Véniant MM, Lu SC, Atangan L, Komorowski R, Stanislaus S, Cheng Y, Wu B, Falsey JR, Hager T, Thomas VA, Ambhaikar M, Sharpsten L, Zhu Y, Kurra V, Jeswani R, Oberoi RK, Parnes JR, Honarpour N, Neutel J, Strande JL. Véniant MM, et al. Among authors: lu sc. Nat Metab. 2024 Feb;6(2):290-303. doi: 10.1038/s42255-023-00966-w. Epub 2024 Feb 5. Nat Metab. 2024. PMID: 38316982 Free PMC article. Clinical Trial.
Four-year clinical update and treatment switching-adjusted outcomes with first-line nivolumab plus ipilimumab with chemotherapy for metastatic non-small cell lung cancer in the CheckMate 9LA randomized trial.
Carbone DP, Ciuleanu TE, Schenker M, Cobo M, Bordenave S, Juan-Vidal O, Menezes J, Reinmuth N, Richardet E, Cheng Y, Mizutani H, Felip E, Zurawski B, Alexandru A, Paz-Ares L, Lu S, John T, Zhang X, Mahmood J, Hu N, De T, Santi I, Penrod JR, Yuan Y, Lee A, Reck M. Carbone DP, et al. Among authors: lu s. J Immunother Cancer. 2024 Feb 12;12(2):e008189. doi: 10.1136/jitc-2023-008189. J Immunother Cancer. 2024. PMID: 38346853 Free PMC article. Clinical Trial.
Tumor-immune microenvironment and NRF2 associate with clinical efficacy of PD-1 blockade combined with chemotherapy in lung squamous cell carcinoma.
Duan J, Zhang Y, Chen R, Liang L, Huo Y, Lu S, Zhao J, Hu C, Sun Y, Yang K, Chen M, Yu Y, Ying J, Huang R, Ma X, Leaw S, Bai F, Shen Z, Cai S, Gao D, Wang J, Wang Z. Duan J, et al. Among authors: lu s. Cell Rep Med. 2023 Dec 19;4(12):101302. doi: 10.1016/j.xcrm.2023.101302. Epub 2023 Dec 4. Cell Rep Med. 2023. PMID: 38052215 Free PMC article.
Neuronal conversion from glia to replenish the lost neurons.
Liang S, Zhou J, Yu X, Lu S, Liu R. Liang S, et al. Among authors: lu s. Neural Regen Res. 2024 Jul 1;19(7):1446-1453. doi: 10.4103/1673-5374.386400. Epub 2023 Oct 2. Neural Regen Res. 2024. PMID: 38051886 Free PMC article.
Gas Phase Transformations in Carbon-11 Chemistry.
Lu S, Telu S, Siméon FG, Cai L, Pike VW. Lu S, et al. Int J Mol Sci. 2024 Jan 18;25(2):1167. doi: 10.3390/ijms25021167. Int J Mol Sci. 2024. PMID: 38256240 Free PMC article. Review.
15,826 results
You have reached the last available page of results. Please see the User Guide for more information.